Details of the Drug

General Information of Drug (ID: DM6NF26)

• Drug Name: V160

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Phase 2	[1]

• Cross-matching ID: TTD ID: D0T7BI

References

• [1] ClinicalTrials.gov (NCT03486834) Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002). U.S. National Institutes of Health.